#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Treatment of tobacco dependence: prevention, diagnosis and treatment in General Practice


Authors: E. Králíková 1,2;  S. Býma 3;  S. Konštacký 3
Authors‘ workplace: Univerzita Karlova v Praze, 1. LF a VFN, Ústav hygieny a epidemiologie Přednosta: prof. MUDr. Vladimír Bencko, DrSc. 1;  Centrum léčby závislosti na tabáku III. interní kliniky 1. LF UK a VFN, Praha Přednosta: prof. MUDr. Štěpán Svačina, DrSc., MBA 2;  Ústav sociálního lékařství LF UK, Hradec Králové Přednosta: prof. PhDr. Jiří Mareš, CSc. 3
Published in: Prakt. Lék. 2008; 88(5): 258-261
Category: Reviews

Overview

Tobacco dependence is the most important preventable cause of morbidity and mortality. Among Czech smokers, about 70 % (1.75 million) would prefer not to smoke; and about 40 % (about 1 million) try to stop each year. Since the majority attempt to quit unaided without medical assistance, the success rate is only about 3%. Effective treatment exists: with intensive intervention and pharmacotherapy the abstinence rates could reach over 30 %. Treatment of tobacco dependence should be offered to all smokers by all physicians, namely by general practitioners. Even if there are time limitations, a short intervention should be offered at the very least. Both Czech and international guidelines for the treatment of tobacco dependence for general practitioners are now available.

Key words:
tobacco dependence treatment, general practitioner.


Sources

1. American Psychiatric Association. Nicotine-induced disorder. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), Washington, 994, p. 244-247.

2. Býma, S., Hradec, J., Herber, O., Karen, I. Prevence kardiovaskulárních onemocnění, Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře. Společnost všeobecného lékařství ČLS JEP, 2004; ISBN 80-903573-5-0. Dostupné na www.svl.cz

3. Cahill, K., Stead, L., Lancaster, T. Nicotine receptor partial agonists for smoking cessation. Cochrane Library (issue 1). Dostupné na http://www.mrw.interscience. wiley.com/cochrane/ clsysrevarticles/CD006103/frame.html

4. Čupka, J., Nešpor, K., Králíková, E. a kol. Léčba závislosti na tabáku v ordinaci praktického lékaře. Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře. Centrum doporučených postupů pro praktické lékaře, nadační fond Praktik, Praha, 2006, 9 s.

5. Fiore, M. C., Bailey, W. C., Cohen, S. J., et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. June 2000. Dostupné na www.surgeongeneral.gov/tobacco

6. Gonzales, D., Rennard, S. I., Nides, M. et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006, 296, 1, p. 47-55.

7. Heatheron, T. F., Kozlowski, L., T., Frecker, R. C., Fagerström, K. O. The fagerström test of nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Brit. J. Addiction, 86, 1991, p. 1119-1127.

8. Hughes, J., Stead, L. F., Lancaster, T. Antidepressants for smoking cessation, Cochrane Database for Systematic reviews, 2006, issue 4. Dostupné na http://www3.interscience.wiley.com/ cgi-bin/mrwhome/106568753/HOME

9. International Primary Care Respiratory Group. Tackling the Smoking Epidemy. IPCRG international guidance on smoking cessation in primary care. Dostupné na http://www.theipcrg.org/ smoking/index.php

10. Jorenby, D. E., Hays, J. T., Rigotti, N. A. et al. Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial, JAMA, 2006, 296, 1, p. 56-63.

11. Miovský, M., Miovská, L. Aktuální situace v užívání návykových látek v ČR a založení nového oboru adiktologie, Prakt. lék., 86, 2006, 3, s. 138-143.

12. Peto, R., Lopez, A. D., Boreham, J. et al. Mortality From Smoking in Developed Countries 1950 - 2000. Oxford, UK: Oxford University Press, 1994, update 2006. Dostupné též na http://www.deathsfromsmoking.net

13. Králíková, E. Prevence závislosti na tabáku. Česko-slovenská pediatrie, 61, 2006, 3, s. 149-154.

14. Králíková, E., Býma, S., Cífková, R. et al. Doporučení pro léčbu závislosti na tabáku. Čas. lék. čes. 144, 2005, 5, s. 327-333.

15. Raw, M., McNeill, A., West, R. Smoking cessation: evidence based recommendations for the healthcare system. BMJ 1999, 318 (7177), p. 182-185.

16. Tonstad, S., Tonnesen, P., Hajek, P. et al. Varenicline Phase 3 Study Group: Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial, JAMA, 2006, 296, 1, p. 64-71.

17. Varenicline. Guidance for health professional on a new prescription-only stop smoking medication. London: ASH, November 2006. Dostupné na http://www.ash.org.uk/files/documents/ASH_447.pdf

18. West, R., McNeill, A., Raw, M. Smoking cessation guidelines for health professionals: an update. Thorax, 2000, 55, p. 987-999.

19. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: World Health Organization, 1992.

20. Býma, S., Herbert, O. Projekt Atlet. Dostupné na http://www.atlet.cz/img/Atlet/atlet_vysledky.ppt.

Labels
General practitioner for children and adolescents General practitioner for adults
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#